Sagent Pharma launches ceftriaxone & cefuroxime injection

Illinois Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, has launched both ceftriaxone for injection, USP, and cefuroxime for injection, USP, two broad spectrum antibiotics for parenteral administration used to treat bacterial infections. Sagent's ceftriaxone for injection will be available to the US market in 250 mg and 500 mg single dose vials, as well as 1g and 2g single dose vials; cefuroxime for injection will be available in 750 mg and 1.5g single dose vials and in 7.5g pharmacy bulk package vials. According to IMS data, combined 2007 sales for the two antibiotics were $156 million. "We are excited to introduce these two broad-spectrum antibiotics, incorporating important features unique to Sagent, including enhanced labelling designed to enable rapid and accurate product... [read full story]